What are the Australian cutoff levels for drug tests and what do they mean to me ?
Firstly, for your peace of mind Pass My Drug Test Australia frequently check the latest Australian standards to ensure our products remain relevant in an ever changing industry. The cutoffs levels listed below are confirmed to still be the accurate Australia-wide industry cutoffs in 2020.
Class of Drug
Amphetamine type substances
Nice numbers, but what do they mean ?
Firstly, the µg/L sign symbolizes micrograms/litre. Drug testing normally involves establishing the concentration of a drug above a certain level rather than just finding the presence of the drug. Interestingly, not many people are aware of this! A “cut-off” is the concentration of a drug at or above which is deemed positive by a laboratory analysis for that drug. Cut-offs are set for laboratory standardisation purposes, the detection period and to exclude defences based upon passive inhalation.
Determining your likely toxicity level is by no means an exact science. People often fall into the trap of just looking at a detection period table and expecting that the time period stated in the table will apply to them. Everybody is different — your situation will differ from others. The time taken to clear naturally from toxins will varely greatly dependent upon the length of exposure to toxins, body fat ratio, general health, lifestyle, strength of toxin, route of administration and many other decisive factors. PassMyDrugTest.com.au have made things as easy as possible for you with an inbuilt calculator to give you an idea of how likely you are to be above, at or below the Australia cut-off levels for drug tests
Drug testing Cut-off levels can be different between Organisations
Some organisations reserve the right to adopt different cut-off levels for various drug classes. This means that anybody purchasing a home test kit should check the relevant cut-off level that might apply before selecting a particular test. Naturally it can be a waste of time and money relying upon a test kit if it uses a different cut-off level to what is actually applied in a policy. In saying that, we have yet to find a reported case in Australia that does not follow the cut-off levels as provided for in the Standards.
The cut-off levels are not exactly the same between countries, for example the opiate cut-off level for urine testing in the United States is 2000ng/ml whereas the cut-off level in Australia for the same drug is 300ng/ml. This is a fairly dramatic difference (US is 666% higher than Australia).
If you’re interested to know more you can read the Australian/New Zealand Standard (AS/NZS 4308:2008). You will most likely be required to pay a fee for a copy of this document. Remember, you can always use the contact us (link to query form) if you have any questions.
This will be handy for those on prescribed drugs. Pass My Drug Test Australia can help you to avoid getting into hot water with your workplace for simply taking your lawfully prescribed medication.
|Amphetamine and methamphetamine||Amantadine|
|Proton pump inhibitorsc|
|Coca leaf teas|
|Poppy seeds and oil|
|Lyseric acid diethylamine (LSD)||Amitriptyline|
1. Standridge JB, Adams SM, Zotos AP. Urine drug screen: a valuable office procedure. Am Fam Physician. 2010;81(5):635-640.
2. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66-76.
3. Quest Diagnostics. Standard urine testing for drug and alcohol abuse. www.questdiagnostics.com/employersolutions/standard_urine_testing_es.html
Accessed Nov 11, 2010.
4. Vincent EC, Zebelman A, Goodwin C. What common substances can cause false positives on urine drug screens for drugs of abuse? J Fam Pract. 2006;55(10):893-894, 897.
5. Brahm NC, Yeager LL, Fox MD, Farmer KC, Palmer TA. Commonly prescribed medications and potential false-positive urine drug screens. Am J Health-Syst Pharm. 2010;67(16):1344-1350.
6. Holtorf K. Ur-ine Trouble. Scottsdale, AZ: Vandalay Press; 1998.
7. Woelfel JA. Drug abuse urine tests: false-positive results. Pharmacist's Letter/Prescriber's Letter. 2005;21(3):210314.